Verve Therapeutics, Inc. Company Information
Verve Therapeutics, Inc.'s employee growth, exchange listings and data sources
Key Information
- Name: Verve Therapeutics, Inc.
- Ticker: VERV
- Exchange: NasdaqGS
- Founded: 2018
- Industry: Biotechnology
- Sector: Pharmaceuticals & Biotech
- Market Cap: US$410.620m
- Shares Outstanding: 84.66m
- Website: https://www.vervetx.com
Number of Employees
Location
- Verve Therapeutics, Inc.
- 201 Brookline Avenue
- Suite 601
- Cambridge
- Massachusetts
- 02215
- United States
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| VERV | NasdaqGS (Nasdaq Global Select) | Yes | Common Stock | US | USD | Jun 2021 |
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/11/24 13:18 |
| End of Day Share Price | 2024/11/22 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.